Boston Scientific BSX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Boston Scientific's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Boston Scientific's investing cash flow?
- Boston Scientific (BSX) reported investing cash flow of -$591M in Q1 2026.
- How has Boston Scientific's investing cash flow changed year-over-year?
- Boston Scientific's investing cash flow decreased by 18.2% year-over-year, from -$500M to -$591M.
- What is the long-term trend for Boston Scientific's investing cash flow?
- Over 4 years (2021 to 2025), Boston Scientific's investing cash flow has grown at a 13.4% compound annual growth rate (CAGR), from -$1.6B to -$2.64B.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.